Q4 2020 Osmotica Pharmaceuticals PLC Earnings Call Transcript
Thank you for standing by and welcome to the Osmotica Q4 2020 Earnings Business Update Conference Call. (Operator Instructions) As a reminder, today's conference call is being recorded. I will now turn the conference over to your host, Ms. Lisa Wilson. Ma'am, you may begin.
Thank you, operator. Welcome to Osmotica Pharmaceuticals Fourth Quarter 2020 Business Update Call. This is Lisa Wilson, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andy Einhorn.
This afternoon, the company issued a press release detailing financial results for the 3 months ended December 31, 2020. This press release and a webcast of this call can be accessed through the Investors section of the Osmotica website at osmotica.com.
Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |